L. Glace, E. T. Grygielko, R. Boyle, Q. Wang, N. J. Laping et al., Estrogen- 307 induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone, p.308, 2009.

D. Habauzit, J. Armengaud, B. Roig, and J. Chopineau, Determination of estrogen presence in water by SPR using estrogen receptor dimerization, Analytical and Bioanalytical Chemistry, vol.1160, issue.Suppl 7, pp.873-883, 2008.
DOI : 10.1007/s00216-007-1725-x

D. Habauzit, A. Boudot, G. Kerdivel, G. Flouriot, and F. Pakdel, Development and validation of a test for environmental estrogens: Checking xeno-estrogen activity by CXCL12 secretion in BREAST CANCER CELL LINES (CXCL-test), Environmental Toxicology, vol.31, issue.Suppl 7, pp.495-503, 2010.
DOI : 10.1002/tox.20594
URL : https://hal.archives-ouvertes.fr/hal-00592335

D. Habauzit, J. Chopineau, and B. Roig, SPR-based biosensors: a tool for biodetection of hormonal compounds, Analytical and Bioanalytical Chemistry, vol.205, issue.7, pp.1215-1223, 2007.
DOI : 10.1007/s00216-006-0958-4

D. Habauzit, F. Ferrière, N. Botherel, G. Flouriot, F. Pakdel et al., Differentiation of PC12 cells 319 expressing estrogen receptor alpha: a new bioassay for endocrine-disrupting chemicals evaluation, 2014.

J. M. Hall and K. S. Korach, Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signaling axis, Molecular Carcinogenesis, vol.71, issue.9, pp.715-725, 2013.
DOI : 10.1002/mc.21913

J. M. Hall and K. S. Korach, Stromal Cell-Derived Factor 1, a Novel Target of Estrogen Receptor Action, Mediates the Mitogenic Effects of Estradiol in Ovarian and Breast Cancer Cells, Molecular Endocrinology, vol.17, issue.5, pp.792-8032002, 2003.
DOI : 10.1210/me.2002-0438

T. Hayashi, Y. Okamoto, K. Ueda, and N. Kojima, Formation of estrogenic products from benzophenone 327 after exposure to sunlight, Toxicol. Lett, vol.167, 2006.

W. D. Isenhower, R. R. Newbold, R. C. Cefalo, K. S. Korach, and J. A. Mclachlan, Absence of estrogenic 329 activity in some drugs commonly used during pregnancy, Biol. Res. Pregnancy Perinatol, vol.7, pp.6-10, 1986.

G. Kerdivel, D. Habauzit, and F. Pakdel, Assessment and molecular actions of endocrine-disrupting 334 chemicals that interfere with estrogen receptor pathways, Int. J. Endocrinol, p.501851, 2013.

G. Kerdivel, L. Guevel, R. Habauzit, D. Brion, F. Ait-aissa et al., Estrogenic potency of 337 benzophenone UV filters in breast cancer cells: proliferative and transcriptional activity substantiated 338 by docking analysis, PloS One, vol.8, 2013.

S. Kim and K. Choi, Occurrences, toxicities, and ecological risks of benzophenone-3, a common component of organic sunscreen products: A mini-review, Environment International, vol.70, pp.143-157, 2014.
DOI : 10.1016/j.envint.2014.05.015

S. Kim, D. Jung, Y. Kho, and K. Choi, Effects of benzophenone-3 exposure on endocrine disruption and 343 reproduction of Japanese medaka (Oryzias latipes)--a two generation exposure study, Aquat. Toxicol, 2014.

Y. Nakagawa, T. Suzuki, and S. Tayama, Metabolism and toxicity of benzophenone in isolated rat hepatocytes and estrogenic activity of its metabolites in MCF-7 cells, Toxicology, vol.156, issue.1, pp.27-36, 2000.
DOI : 10.1016/S0300-483X(00)00329-2

A. Ferrari and T. Florio, 17beta-estradiol promotes breast cancer cell proliferation-inducing stromal 366 cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib 367 pretreatment, Mol. Pharmacol, vol.73, pp.191-202, 2008.

M. P. Roberti, J. M. Arriaga, M. Bianchini, H. R. Quintá, A. I. Bravo et al., Protein expression changes during human triple negative breast cancer cell line progression to 370 lymph node metastasis in a xenografted model in nude mice, Cancer Biol. Ther, vol.369, issue.13, pp.2012-1123

R. Rodríguez-gómez, I. Jiménez-díaz, A. Zafra-gómez, O. Ballesteros, and A. Navalón, A multiresidue method for the determination of selected endocrine disrupting chemicals in human breast milk based on a simple extraction procedure, Talanta, vol.130, pp.561-570, 2014.
DOI : 10.1016/j.talanta.2014.07.047

M. E. Mcmaster, D. L. Villeneuve, and M. R. Embry, Alternatives to in vivo tests to detect endocrine 377 disrupting chemicals (EDCs) in fish and amphibians--screening for estrogen, androgen and thyroid 378 hormone disruption, Crit. Rev. Toxicol, vol.43, pp.45-72, 2013.

A. M. Soto, J. T. Murai, P. K. Siiteri, and C. Sonnenschein, Control of cell proliferation: evidence for negative 380 control on estrogen-sensitive T47D human breast cancer cells, Cancer Res, vol.46, pp.2271-2275, 1986.

A. M. Soto, C. Sonnenschein, K. L. Chung, M. F. Fernandez, N. Olea et al., The E-SCREEN 382 assay as a tool to identify estrogens: an update on estrogenic environmental pollutants, Environ. Health, vol.383, 1995.

. Occurrence, distribution and ecological risk assessment of multiple classes of UV filters in 386 surface waters from different countries, Water Res, vol.67, pp.55-65

F. Vela-soria, O. Ballesteros, A. Zafra-gómez, L. Ballesteros, and A. Navalón, A multiclass method for the analysis of endocrine disrupting chemicals in human urine samples. Sample treatment by dispersive liquid???liquid microextraction, Talanta, vol.129, pp.209-218, 2014.
DOI : 10.1016/j.talanta.2014.05.016

K. Yoon, S. J. Kwack, H. S. Kim, and B. Lee, Estrogenic Endocrine-Disrupting Chemicals: Molecular Mechanisms of Actions on Putative Human Diseases, Journal of Toxicology and Environmental Health, Part B, vol.129, issue.3, pp.127-392, 2014.
DOI : 10.1210/en.2005-0565